drugset / Trial / NCT00772447
China Registration Study in Patients With Skin Infections
RandomizedParallel-groupSingle-blindTreatment
Summary
The objectives of this study is to evaluate the Safety and Efficacy of Intravenous Daptomycin (Cubicin®)Compared with that of Comparator (Vancomycin or Vancomycin Followed by Semi-synthetic Penicillin-cloxacillin) in the Treatment of Chinese Subjects with Complicated Bacterial Skin and Skin Structure Infection due to Gram-Positive Pathogens.
Timeline
- Start
- 2008-09
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daptomycin | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Vancomycin | Other / unclassified | 1 g | — |
| Comparator | Vancomycin | Other / unclassified | 2 g | — |
| Comparator | cloxacillin | Other / unclassified | 1 g | — |
| Comparator | cloxacillin | Other / unclassified | 2 g | — |